Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • adhalleran
    Junior Member
    • Jun 2015
    • 1

    #1

    Low computation usage on AWS using Galaxy

    Hi Everyone,

    I am attempting to analyze HiSeq 2500 RNA-Seq data using a Galaxy instance run through AWS, but the analysis is taking an unexpectedly long time (to run around 10M reads through Tophat using XenTro2 as the reference genome has taken over 3 hours and no end is in sight.)

    Looking at the core usage on AWS monitor it appears that the Galaxy instance is only using 8% of a c3.8xlarge (with autoscaling set to allow it to use up to four c3.8xlarge if needed).

    Is this normal? Is there a way to push Tophat to use more of the computing resources available through AWS?

    Thanks
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Are you using a prebuilt galaxy image? It is may be configured to use only one core for tophat. If you are not comfortable using command line/have good knowledge of aws it may be more trouble than it is worth to go modifying configs.

    You may want to install tophat directly in your aws instance and use that instead of galaxy.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 10:52 AM
    0 responses
    9 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    19 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-13-2026, 09:56 AM
    0 responses
    16 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-09-2026, 11:14 AM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...